Parameter | Base estimate and alternatives | Source |
---|---|---|
Costs: | Â | Â |
ACT | $1.8 (adult dose) | Uganda MoH |
Antibiotic | $0.4 (adult dose) | Primary data – Joint Medical Store |
pLDH RDT | $.51 | Manufacturer |
HRP2 RDT | $.55 | Manufacturer |
Harm of treatment with ACT (or antibiotic) | Every 200/2000 ACT doses currently used result in the loss of one statistical life | [11] |
Inpatient care severe malaria | $12 | Primary data, Kisiizi Hospital |
Inpatient care severe NMFI | $20 | Â |
Accuracies: | Â | Â |
pLDH sensitivity | 77.1% | Primary trial data |
pLDH specificity | 98.4% | Primary trial data |
HRP2 sensitivity | 98.8% | Primary trial data |
HRP2 specificity | 87.0% | Primary trial data |
Illness progression probabilities: | Â | Â |
Adherence | Full adherence -100% | Variable in model |
Year of Life Lost (YLL) | $150, $840 | [29-31] |